Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review. - Wikidata - awgldk - TriplyDB

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

http://www.wikidata.org/entity/Q37307724

about

Hodgkin's lymphoma therapy: past, present, and future.Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement.

P2860

Q34296914-08C01705-757C-4D01-BC9B-40BB7FF89271 Q35478934-BC5F4BCB-66C3-400C-9281-0A64E2C90B0B Q43265564-CB5C0BE2-6FA0-4DB8-AC0E-9AF8FA41402E

P2860

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

http://www.wikidata.org/entity/Q37307724

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

@en

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

@nl

type

label

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

@en

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

@nl

prefLabel

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

@en

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

@nl

P1433

Q37307724-18A980C1-5E0B-464F-B73E-CAE567E48FDB

P1476

Q37307724-637A6C2D-0D8A-46CD-B0B2-5DE96A3BC8AB

P2093

Q37307724-C05DD49D-7D7E-4915-8141-6E09AC38EA5E

P2860

Q37307724-1BDEAF75-8D44-4C67-BA0D-B6A0B5036856

Q37307724-2E64CBC6-D392-4C16-806F-4E1C785488B1

Q37307724-2ECA7418-595A-452D-972D-2D558EC7AC9D

Q37307724-34AC7289-2AAD-4FDB-81C2-3322C11176AB

Q37307724-35F413BD-8F55-4684-9B50-5B62D34D2CBE

Q37307724-4370ED99-EE2F-49BC-A839-0E05A6B71335

Q37307724-7EE582A0-01DB-4CC5-A8E8-216AA68B1CC0

Q37307724-9643051E-5CCE-4198-9A98-80C81C900090

Q37307724-97184BF9-E5B1-4343-977A-42C681EA9E29

Q37307724-9E4025A6-F07D-4084-90AA-AD6F9D29EA5A

P304

Q37307724-288A0DEB-4ED8-404F-B23A-C418421B8DE1

P31

Q37307724-30FC86D8-3C04-40B3-942A-BD6942778DC4

P356

Q37307724-94A58466-E44E-408E-B26A-17D8258AF4D5

P433

Q37307724-557A5100-00E8-46A2-AB1A-0EDE531A03C5

P478

Q37307724-51D483CB-05C6-4A3B-8919-71787799FC39

P577

Q37307724-9562CAEE-55C4-4DBC-9395-6493A30DF6D8

P698

Q37307724-A90E6D35-884B-4ECB-ADD3-1D3010CDD5D0

P356

10428190802304974

P1433

Leukemia & Lymphoma

P1476

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.

@en

P2093

Ginna G Laport

http://www.w3.org/2001/XMLSchema#string

P2860

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial.

Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.

Early interim PET scan in Hodgkin lymphoma: where do we stand?

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.

Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol.

P304

1854-1859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428190802304974

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18949609

http://www.w3.org/2001/XMLSchema#string